Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 601-489-9 | CAS number: 1176-81-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute toxicity (LD50) of fluocortolone-A-acetate in rats is > 2000 mg/kg bw after oral administration (Stark and Amir, 1998) and after dermal application (Stark and Wick, 1998).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Aug to Sep 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- 22 March 1996
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- - but a QA check was not performed
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Schering AG
- Females (if applicable) nulliparous and non-pregnant: [yes/no]
- Weight at study initiation: males: 103-117 g; females: 100-106 g
- Fasting period before study: ca. 17.5 to 19 h
- Housing: conventional
- Diet (e.g. ad libitum): pell. Altromin® ad libitum
- Water (e.g. ad libitum): demineralized acidified water, pH 2-3 ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-22
- Humidity (%): 52-64
- Photoperiod (hrs dark / hrs light): 12/12
- Route of administration:
- oral: gavage
- Vehicle:
- other: 900 mg NaCl + 85 mg Myrj 53 ad 100 ml bidest water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
DOSAGE PREPARATION (if unusual): The formulation was prepared freshly on application day and the administrations were carried out within approximately 2 h.
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: on day 8 and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No animal died after administration of 2000 mg/kg bw.
- Clinical signs:
- other: The administration of 2000 mgkg bw was tolerated without compound-related clinical findings.
- Gross pathology:
- Necropsy revealed no compound-related findings after 2000 mg/kg bw.
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The LD50 of the test item in male and female rats after a single i.g. administration is > 2000 mg/kg body weight.
- Executive summary:
In an acute oral toxicity study according to OECD test guideline 423 (1996), groups of fasted, young adult Wistar rats (3/sex) were given a single oral dose of Fluocortolone acetate (100% a.i.) in 900 mg NaCl + 85 mg Myrj 53 ad 100 ml bidest water at a dose 2000 mg/kg bw and observed for 14 days.
Oral LD50 Combined ≥ 2000 mg/kg bw
No Mortality nor clinical signs occurred in this limit test.
Fluocortolone is of low toxicity based on the LD50 in male and female Wistar rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- 24 February 1987
- Deviations:
- yes
- Remarks:
- 3 instead of 5 animals/sex used
- GLP compliance:
- yes
- Remarks:
- - but a QA check was not performed
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Schering AG
- Weight at study initiation: males: 278-282 g; females: 204-207g
- Housing: individually under conventional conditions
- Diet (e.g. ad libitum): pell. Altromin® R ad libitum
- Water (e.g. ad libitum): demineralized acidified water, pH 2-3 ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22
- Humidity (%): 64-66
- Photoperiod (hrs dark / hrs light): 12/12
- Type of coverage:
- occlusive
- Vehicle:
- other: liquid paraffin
- Details on dermal exposure:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit):
step I: 556 and 564 mg ZK 47525 + 0.6 mL vehicle
step I: 556 mg ZK 47525 + 0.5 mL vehicle
step II: 408-414mg ZK 47525 + 0.5 mL vehicle
- For solids, paste formed: yes
- Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Day 1, 7 and 14
- Necropsy of survivors performed: yes
- Clinical signs including body weight: The comparison of the individual values revealed a decrease in body weight gain in male animals dosed with 2000 mg of the test item between day 1 and day 7 of the test. Two male animals (nos. 232; 234) showed even a body weight loss at this time-point. On day 14 the above-mentioned animals showed a body weight gain in the normal range wh ich was routinely observed in our laboratory. No compound-related findings were observed in body weight gain in female animals. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No animal died after administration of 2000 mg/kg bw.
- Clinical signs:
- other: A single dermal application of 2000 mg/kg was tolerated without compound-related findings.
- Gross pathology:
- Necropsy revealed no compound-related findings after 2000 mg/kg bw.
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The LD50 of ZK 47525 in male and female rats after a single dermal application is > 2000 mg/kg body weight. Local application was tolerated without irritation of the skin.
- Executive summary:
In an acute dermal toxicity study according to OECD test guideline 402, groups of young adult Wistar rats (3/sex) were dermally exposed to Fluocortolone acetate (100% a.i) in liquid paraffin for 24 hours at a dose of 2000 mg/kg bw. Animals then were observed for 14 days.
Dermal LD50 Combined ≥ 2000 mg/kg bw
No mortality nor clinical signs occurred in this limit test.
Fluocortolone acetate is of low Toxicity based on the LD50 value for male and female Wistar rats.
The single dermal administration of 2000 mg of the test item/kg was tolerated without compound-related clinical findings.
The comparison of the individual values revealed a decrease in body weight gain in male animals dosed with 2000 mg of the substance between day 1 and day 7 of the test. Two male animals (nos. 232; 234) showed even a body weight loss at this time-point. On day 14 the above-mentioned animals showed a body weight gain in the normal range which was routinely observed in our laboratory. No compound-related findings were observed in body weight gain in female animals.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Additional information
A single oral administration (gavage) of the test substance to male and female rats at the limit-dose 2000 mg/kg bw was tolerated without mortalities, clinical signs, effects on body weight gain and gross pathological findings (Stark and Amir, 1998). According to OECD TG 423 the oral LD50 of ZK 47525 (fluocortolone-A-acetate) in male and female rats is therefore > 2000 mg/kg bw.
A single dermal administration of the test substance to male and female rats at the limit-dose 2000 mg/kg was tolerated without mortalities, compound-related clinical findings, effects on body weight gain and gross pathological findings (Stark and Wick, 1998). According to OECD TG 402 the dermal LD50 of ZK 47525 (fluocortolone-A-acetate) in male and female rats is therefore > 2000 mg/kg bw.
Justification for classification or non-classification
Based on the study results a classification according to Regulation (EC) No. 1272/2008 (CLP) is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.